During EMT, tumor cells, which are epithelial-like cells, acquire mesenchymal characteristics, and the loss of the epithelial marker E-cadherin leads to an increase in the mesenchymal markers N-cadherin, fibronectin, and vimentin [17]. This evidence concerns the gene CDH2 and neoplasm.